Focus on patients receiving long-term antimicrobial treatments for lyme borreliosis: No lyme but mostly mental disorders

Infect Dis Now. 2021 May;51(3):300-303. doi: 10.1016/j.medmal.2020.10.018. Epub 2020 Oct 21.

Abstract

Objectives: Overdiagnosis of lyme borreliosis leads to unnecessary and increasingly common antimicrobial treatments. We aimed to evaluate patients receiving long-term antimicrobial treatment for lyme borreliosis.

Methods: We included patients referred to a Parisian teaching hospital between January 1st, 2014 and June 30th, 2019, with a presumed diagnosis of lyme borreliosis for which they were treated with antimicrobials for at least 6 months.

Results: Fifteen patients were included (11 women and mean age 44 years). The mean antimicrobial treatment duration was 476 days (180-942). The mean number of antimicrobials was 6.8 per patient (1-18). None of the 15 patients had lyme borreliosis. Nine patients were diagnosed with a mental disorder.

Conclusion: Overdiagnosis and overtreatment of lyme borreliosis put patients at risk of undiagnosed illnesses and multiple adverse effects of unjustified treatments. The clinical management of such patients requires a comprehensive approach including expertise in mental disorders.

Keywords: Antimicrobials; Lyme borreliosis; Somatic symptoms and related disorders.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage*
  • Diagnosis, Differential
  • Female
  • Humans
  • Lyme Disease / diagnosis*
  • Lyme Disease / drug therapy*
  • Male
  • Medical Overuse
  • Mental Disorders / diagnosis*
  • Middle Aged
  • Retrospective Studies
  • Time Factors
  • Young Adult

Substances

  • Anti-Bacterial Agents